154 related articles for article (PubMed ID: 9342770)
21. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum.
Baureithel KH; Büter KB; Engesser A; Burkard W; Schaffner W
Pharm Acta Helv; 1997 Jun; 72(3):153-7. PubMed ID: 9204773
[TBL] [Abstract][Full Text] [Related]
22. Modulation of cytokine expression by hypericum extract.
Thiele B; Brink I; Ploch M
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S60-2. PubMed ID: 7857513
[TBL] [Abstract][Full Text] [Related]
23. Herbal healers.
McIntyre RV
J Okla State Med Assoc; 1998 Aug; 91(5):271. PubMed ID: 9714967
[No Abstract] [Full Text] [Related]
24. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus.
Butterweck V; Böckers T; Korte B; Wittkowski W; Winterhoff H
Brain Res; 2002 Mar; 930(1-2):21-9. PubMed ID: 11879791
[TBL] [Abstract][Full Text] [Related]
25. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen.
Bernd A; Simon S; Ramirez Bosca A; Kippenberger S; Diaz Alperi J; Miquel J; Villalba Garcia JF; Pamies Mira D; Kaufmann R
Photochem Photobiol; 1999 Feb; 69(2):218-21. PubMed ID: 10048312
[TBL] [Abstract][Full Text] [Related]
26. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
Müller WE; Singer A; Wonnemann M; Hafner U; Rolli M; Schäfer C
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():16-21. PubMed ID: 9684943
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic effects of St. John's Wort on rat intracerebral field potentials.
Dimpfel W; Hofmann R
Eur J Med Res; 1995 Dec; 1(3):157-67. PubMed ID: 9389678
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat.
Franklin M; Chi JD; Mannel M; Cowen PJ
J Psychopharmacol; 2000; 14(4):360-3. PubMed ID: 11198053
[TBL] [Abstract][Full Text] [Related]
30. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Staffeldt B; Kerb R; Brockmöller J; Ploch M; Roots I
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S47-53. PubMed ID: 7857509
[TBL] [Abstract][Full Text] [Related]
32. Is St. John's wort (Hypericum perforatum) an effective antidepressant?
Cott JM; Fugh-Berman A
J Nerv Ment Dis; 1998 Aug; 186(8):500-1. PubMed ID: 9717868
[TBL] [Abstract][Full Text] [Related]
33. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
34. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
Bhattacharya SK; Chakrabarti A; Chatterjee SS
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():22-9. PubMed ID: 9684944
[TBL] [Abstract][Full Text] [Related]
35. [Hypericum perforatum in psychiatric practice].
Kasper S
Nervenarzt; 1997 Feb; 68(2 Suppl):8. PubMed ID: 9173322
[No Abstract] [Full Text] [Related]
36. Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats.
Vandenbogaerde A; Zanoli P; Puia G; Truzzi C; Kamuhabwa A; De Witte P; Merlevede W; Baraldi M
Pharmacol Biochem Behav; 2000 Apr; 65(4):627-33. PubMed ID: 10764915
[TBL] [Abstract][Full Text] [Related]
37. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids.
Denke A; Schempp H; Weiser D; Elstner EF
Arzneimittelforschung; 2000 May; 50(5):415-9. PubMed ID: 10858868
[TBL] [Abstract][Full Text] [Related]
38. [Chemical composition of Hypericum perforatum and its effects].
Nervenarzt; 1997 Feb; 68(2 Suppl):3-4. PubMed ID: 9173320
[No Abstract] [Full Text] [Related]
39. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
40. St John's wort, a herbal antidepressant, activates the steroid X receptor.
Wentworth JM; Agostini M; Love J; Schwabe JW; Chatterjee VK
J Endocrinol; 2000 Sep; 166(3):R11-6. PubMed ID: 10974665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
